HTG Molecular Diagnostics
HTGM
$0.48
Share price
0.00%
Change (1 day)
-96.26%
Change (1 year)
Categories
P/S ratio for HTG Molecular Diagnostics (HTGM)
P/S ratio as of May 2024 (TTM): 0.1669
According to HTG Molecular Diagnostics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.166948. At the end of 2023 the company had a P/S ratio of 0.4444.
P/S ratio history for HTG Molecular Diagnostics from 2015 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 0.4444 | -30.68% |
| 2022 | 0.6411 | -86.08% |
| 2021 | 4.61 | 73.4% |
| 2020 | 2.66 | 25.08% |
| 2019 | 2.12 | -37.12% |
| 2018 | 3.38 | 96.28% |
| 2017 | 1.72 | -44.21% |
| 2016 | 3.08 | -58.24% |
| 2015 | 7.38 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Lexicon Pharmaceuticals
LXRX | 347 | 207,981.56% | 🇺🇸 USA |
 Affimed
AFMD | 9.01 | 5,296.40% | 🇩🇪 Germany |
 Calithera Biosciences
CALA | N/A | N/A | 🇺🇸 USA |